Searched for
DIGITAL PATHOLOGY
Agilent to buy pathology software maker Proscia for $240 millionAgilent Technologies has revealed plans to acquire Proscia for $240 million in cash, along with possible performance bonuses. Proscia is kn...- Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here's whyMotilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong ...
- Neuberg Diagnostics consolidates its Maharashtra operations with NM MedicalNeuberg Diagnostics has consolidated its operations with NM Medical in Maharashtra to enhance diagnostic and preventive healthcare. This pa...
- Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerag...
- These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos have upside potential of up to 28%, according to analystsWith each passing day, things are getting more complicated in the Gulf region – as well as in the market. When will things get sorted out? ...
- Meet Tanishq Matthew Abraham, the 21-year-old American prodigy who graduated high school at 10, earned 3 degrees by 11 and published research at 14Tanishq Matthew Abraham graduated high school at age ten and earned three degrees by eleven. He obtained his Ph.D. in Biomedical Engineerin...
- Psychology says people who worship their idols in sports, politics, cinema or business aren't just fans: What this behaviour reveals?Psychology says people who worship their idols in sports, politics, cinema or business aren't always showing simple admiration. Excessive i...
- Which stocks should you buy ahead of the festive season? Here are Kotak Securities’ top 10 picksIndia’s festive season is expected to drive a strong consumption boost, with analysts identifying sectors and stocks that could benefit. Th...
- Mahajan Imaging, Neuberg Diagnostics join hands to scale pathology, genomics in North IndiaMahajan Imaging and Neuberg Diagnostics have formed a strategic joint venture. This partnership aims to expand pathology and genomics servi...
- Psychology says people who save screenshots they never look at may be collecting a sense of future securityPeople may save screenshots for all kinds of reasons: they expect the information could be useful later, don't want to risk forgetting it, ...
- Why rural healthcare needs India’s entrepreneurs to step inRural healthcare will not be transformed by building more of the same. The next phase will require private companies, entrepreneurs, and te...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- Psychology says people who bookmark dozens of articles but rarely read them may be collecting possibilities rather than informationThe person with hundreds of unread bookmarks may not be collecting knowledge. They may be collecting potential knowledge. Each article repr...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- LifeCell International partners with Shraddha Diagnostics to expand advanced diagnostics across GujaratThe company said that the partnership will combine Shraddha Diagnostics' regional presence, clinician relationships and expertise in routin...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
- Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...
Load More
